Sharing real-world data for public benefit: a qualitative exploration of stakeholder views and perceptions

被引:3
|
作者
Baxter, Susan [1 ]
Franklin, Matthew [1 ]
Haywood, Annette [1 ]
Stone, Tony [1 ]
Jones, Monica [2 ]
Mason, Suzanne [1 ]
Sterniczuk, Kamil
机构
[1] Univ Sheffield, Sch Hlth & Related Res ScHARR, 30 Regent St, Sheffield, England
[2] Univ Leeds, Profess Serv, Woodhouse Lane, Leeds LS29JT, England
关键词
Data sharing; Real world data; Public health; Routine data; Information governance; Integrated care; Qualitative;
D O I
10.1186/s12889-023-15035-w
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundThere has been an increasing interest in the use of "real-world" data to inform care decision making that could lead to public health benefit. Routinely collected service and activity data associated with the administration of care services and service-users (such as electronic health records or electronic social care records), hold potential to better inform effective and responsive decision-making about health and care services provided to national and local populations. This study sought to gain an in-depth understanding regarding the potential to unlock real world data that was held in individual organisations, to better inform public health decision-making. This included sharing data between and within health service providers and local governing authorities, but also with university researchers to inform the evidence base.MethodsWe used qualitative methods and carried out a series of online workshops and interviews with stakeholders (senior-level decision-makers and service leads, researchers, data analysts, those with a legal and governance role, and members of the public). We identified recurring themes in initial workshops, and explored these with participants in subsequent workshops. By this iterative process we further refined the themes identified, compared views and perceptions amongst different stakeholder groups, and developed recommendations for action.ResultsOur study identified key elements of context and timing, the need for a different approach, and obstacles including governmental and legal, organisational features, and process factors which adversely affect the sharing of real world data. The findings also highlighted a need for improved communication about data for secondary uses to members of the public.ConclusionThe Covid-19 pandemic context and changes to organisational structures in the health service in England have provided opportunities to address data sharing challenges. Change at national and local level is required, within current job roles and generating new jobs roles focused on the use and sharing of real-world data. The study suggests that actions can be taken to unlock the potential of real-world data for public health benefit, and provides a series of recommendations at a national level, for organisational leaders, those in data roles and those in public engagement roles.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Sharing real-world data for public benefit: a qualitative exploration of stakeholder views and perceptions
    Susan Baxter
    Matthew Franklin
    Annette Haywood
    Tony Stone
    Monica Jones
    Suzanne Mason
    Kamil Sterniczuk
    BMC Public Health, 23
  • [2] Use of Real-World Data Sources for Canadian Drug Pricing and Reimbursement Decisions: Stakeholder Views and Lessons for Other Countries
    Husereau, Don
    Nason, Edward
    Ahuja, Tarun
    Nikai, Enkeleida
    Tsakonas, Eva
    Jacobs, Philip
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2019, 35 (03) : 181 - 188
  • [3] Developing Data Sharing Models for Health Research with Real-World Data: A Scoping Review of Patient and Public Preferences
    Hermansen, Anna
    Regier, Dean A.
    Pollard, Samantha
    JOURNAL OF MEDICAL SYSTEMS, 2022, 46 (12)
  • [4] Developing Data Sharing Models for Health Research with Real-World Data: A Scoping Review of Patient and Public Preferences
    Anna Hermansen
    Dean A. Regier
    Samantha Pollard
    Journal of Medical Systems, 46
  • [5] What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews
    Makady, Amr
    de Boer, Anthonius
    Hillege, Hans
    Klungel, Olaf
    Goettsch, Wim
    VALUE IN HEALTH, 2017, 20 (07) : 858 - 865
  • [6] Data Science Methods for Real-World Evidence Generation in Real-World Data
    Liu, Fang
    ANNUAL REVIEW OF BIOMEDICAL DATA SCIENCE, 2024, 7 : 201 - 224
  • [7] Editorial: Real-world data and real-world evidence in lung cancer
    Gristina, Valerio
    Eze, Chukwuka
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [8] Editorial: Real-world data and real-world evidence in hematologic malignancies
    Malagola, Michele
    Ohgami, Robert
    Greco, Raffaella
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] When can real-world data generate real-world evidence?
    Rahman, Motiur
    Dal Pan, Gerald
    Stein, Peter
    Levenson, Mark
    Kraus, Stefanie
    Chakravarty, Aloka
    Rivera, Donna R.
    Forshee, Richard
    Concato, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [10] Are polypharmacy side effects predicted by public data still valid in real-world data?
    Kee, Gaeun
    Kang, Hee Jun
    Ahn, Imjin
    Gwon, Hansle
    Kim, Yunha
    Seo, Hyeram
    Choi, Heejung
    Cho, Ha Na
    Kim, Minkyoung
    Han, Jiye
    Park, Seohyun
    Kim, Kyuwoong
    Jun, Tae Joon
    Kim, Young-Hak
    HELIYON, 2024, 10 (02)